Ghdc Antibody

What is GHDC and what is known about its biological function?

GHDC (GH3 domain-containing protein) is a protein that belongs to the GH3 family. According to current research, GHDC is:

• Highly expressed in normal mammary tissues and mammary tumors

• Primarily located in the nuclear envelope

• In mouse, its gene is located on chromosome 11 adjacent to the STAT3/5 locus

The biological function of GHDC remains largely unknown, making it an interesting target for exploratory research. Its high expression in mammary tissues suggests potential roles in breast tissue biology or pathology, but definitive functional characterization is still limited in the current literature.

What applications are validated for GHDC antibodies?

GHDC antibodies have been validated for multiple research applications with specific recommendations:

When designing experiments, researchers should optimize antibody concentrations for their specific sample types and detection systems.

How should researchers validate GHDC antibody specificity?

Validating antibody specificity is critical for reliable research results. For GHDC antibodies, researchers should:

• Perform Western blot analysis on known GHDC-expressing tissues (e.g., breast tissue) and observe a band at the expected molecular weight (~68 kDa observed; 57.5 kDa calculated)

• Include positive controls (e.g., 293 cell lysate, which has been validated)

• Consider knockdown/knockout validation where GHDC expression is reduced through siRNA or CRISPR

• Test multiple antibody dilutions to optimize signal-to-noise ratio

• Verify staining pattern consistency with known subcellular localization (nuclear envelope)

Cross-reactivity should be assessed against multiple isoforms, as multiple GHDC isoforms are known to exist .

What are the optimal protocols for using GHDC antibodies in Western blot analysis?

Based on validated methodologies, the following protocol is recommended for Western blot analysis:

• Sample preparation:

  • Lyse cells in standard RIPA buffer with protease inhibitors

  • Load 20-30 μg total protein per lane

  • Include 293 cell lysate as a positive control

• Electrophoresis and transfer:

  • Use standard SDS-PAGE conditions (10-12% gel recommended)

  • Transfer to PVDF or nitrocellulose membrane

• Antibody incubation:

  • Block membrane in 5% non-fat milk or BSA for 1 hour

  • Incubate with GHDC primary antibody at 0.5-1 μg/mL overnight at 4°C

  • Wash 3x in TBST

  • Incubate with appropriate HRP-conjugated secondary antibody

  • Wash 3x in TBST

• Detection:

  • Develop using standard ECL reagents

  • Expected molecular weight: ~68 kDa

• Controls:

  • Positive control: 293 cell lysate

  • Loading control: Housekeeping protein (β-actin, GAPDH)

How should researchers design immunohistochemistry experiments with GHDC antibodies?

For effective immunohistochemistry with GHDC antibodies:

• Tissue preparation:

  • Fix tissues in 10% neutral buffered formalin

  • Embed in paraffin and section at 4-5 μm thickness

  • Perform heat-induced epitope retrieval (HIER) using citrate buffer (pH 6.0)

• Staining protocol:

  • Block endogenous peroxidase (3% H₂O₂, 10 min)

  • Block non-specific binding (5% normal serum, 1 hour)

  • Incubate with GHDC antibody at 1:20-1:50 dilution

  • Apply appropriate detection system (e.g., HRP-polymer)

  • Counterstain with hematoxylin

• Controls and validation:

  • Include known positive tissue (breast tissue)

  • Include negative control (omit primary antibody)

  • Use multiple tissue types for cross-validation (e.g., tissue microarray)

• Analysis recommendations:

  • Score staining intensity (0-3+)

  • Assess percentage of positive cells

  • Evaluate subcellular localization pattern (nuclear envelope staining expected)

What approaches can researchers use to study GHDC expression in relation to mammary biology?

Since GHDC is highly expressed in mammary tissues, several approaches can be used:

• Expression analysis across developmental stages:

  • Compare GHDC expression in normal breast tissue at different developmental stages

  • Use immunohistochemistry and Western blot to quantify expression levels

  • Correlate with hormonal status and developmental markers

• Comparative analysis in normal vs. tumor tissues:

  • Create tissue microarrays with normal breast tissue and various breast cancer subtypes

  • Quantify GHDC expression using validated antibodies

  • Correlate expression with tumor grade, molecular subtype, and clinical outcomes

• Co-localization studies:

  • Perform dual immunofluorescence with GHDC antibody and nuclear envelope markers

  • Use confocal microscopy to confirm subcellular localization

  • Investigate potential protein-protein interactions through co-immunoprecipitation

• Functional studies:

  • Manipulate GHDC expression through knockdown/overexpression

  • Assess effects on cell proliferation, migration, and differentiation

  • Investigate potential interactions with STAT3/5 pathway given chromosomal proximity in mouse models

How can researchers use GHDC antibodies in multiplexed imaging applications?

Multiplexed imaging can provide insights into GHDC's relationship with other proteins:

• Antibody selection for multiplexing:

  • Choose GHDC antibodies raised in rabbit or mouse to allow compatibility with other antibodies

  • Validate antibody performance in multiplexed conditions

  • Ensure minimal cross-reactivity between detection systems

• Imaging protocols:

  • For immunofluorescence, start with GHDC antibody at 20 μg/mL

  • Use fluorophore-conjugated secondary antibodies with minimal spectral overlap

  • Include appropriate blocking steps between antibody incubations

  • For cyclic immunofluorescence, validate antibody performance after stripping/reprobing

• Analysis considerations:

  • Employ image analysis software to quantify co-localization

  • Use appropriate statistical methods to assess spatial relationships

  • Consider machine learning approaches for pattern recognition in complex datasets

What are the challenges in interpreting conflicting results from different GHDC antibodies?

Researchers may encounter discrepancies when using different GHDC antibodies:

• Sources of variability:

  • Epitope differences: Antibodies targeting different regions of GHDC may yield different results

  • Isoform specificity: Multiple GHDC isoforms exist that may be detected differently

  • Technical factors: Fixation, antigen retrieval, and detection methods can affect results

• Resolution strategies:

  • Compare immunogen sequences between antibodies to understand epitope differences

  • Validate results with multiple antibodies targeting different GHDC epitopes

  • Correlate protein detection with mRNA expression (e.g., using RT-PCR or RNA-seq)

  • Use genetic approaches (siRNA, CRISPR) to confirm specificity

• Reporting recommendations:

  • Clearly specify which GHDC antibody was used (catalog number, lot)

  • Report all experimental conditions in detail

  • Acknowledge limitations and potential confounding factors

How can researchers optimize immunoprecipitation protocols with GHDC antibodies?

For successful immunoprecipitation (IP) of GHDC:

• Buffer optimization:

  • Test multiple lysis buffers to preserve protein-protein interactions

  • For nuclear envelope proteins like GHDC, include nuclear extraction steps

  • Add protease and phosphatase inhibitors to prevent degradation

• IP protocol recommendations:

  • Pre-clear lysates to reduce non-specific binding

  • Use 1-5 μg antibody per 500 μg total protein

  • Consider crosslinking antibody to beads to prevent antibody contamination

  • Include appropriate negative controls (isotype control antibody, beads alone)

• Validation strategies:

  • Confirm IP efficiency by Western blot of input, flow-through, and IP fractions

  • Validate co-IP results by reciprocal IP when possible

  • Consider mass spectrometry to identify novel interaction partners

What quantitative methods are recommended for analyzing GHDC expression data?

For reliable quantification of GHDC expression:

• Western blot quantification:

  • Use digital imaging systems with a linear dynamic range

  • Normalize GHDC signal to loading controls

  • Include a standard curve of recombinant protein when absolute quantification is needed

  • Use technical and biological replicates (minimum n=3)

• Immunohistochemistry quantification:

  • Employ digital pathology methods for objective scoring

  • Consider H-score method (intensity × percentage positive cells)

  • Use automated image analysis software for consistent scoring

  • Validate scoring with multiple independent observers

• Statistical considerations:

  • Apply appropriate statistical tests based on data distribution

  • Consider non-parametric methods for ordinal data (IHC scoring)

  • Account for multiple testing when analyzing large datasets

  • Report effect sizes alongside p-values

How do researchers troubleshoot common issues with GHDC antibodies?

How can researchers integrate GHDC expression data with other biomolecular datasets?

For comprehensive biological insights:

• Multi-omics integration approaches:

  • Correlate GHDC protein expression with transcriptomic data

  • Analyze GHDC in the context of interacting proteins and pathways

  • Use publicly available datasets to examine GHDC expression across tissues/conditions

• Analytical methods:

  • Apply dimensionality reduction techniques (PCA, t-SNE) for visualization

  • Use correlation analysis to identify co-expressed genes/proteins

  • Consider pathway enrichment analysis to understand functional context

  • Apply machine learning for pattern recognition in complex datasets

• Validation strategies:

  • Confirm key findings with orthogonal methods

  • Test hypotheses generated from integrated analysis with targeted experiments

  • Consider temporal dynamics by analyzing expression at multiple time points

What emerging technologies may enhance GHDC antibody research?

Several cutting-edge approaches could advance GHDC research:

• Single-cell protein analysis:

  • Apply mass cytometry (CyTOF) for high-dimensional protein profiling

  • Use single-cell Western blotting for heterogeneity assessment

  • Explore spatial proteomics to map GHDC in intact tissues

• Advanced imaging techniques:

  • Super-resolution microscopy to precisely localize GHDC within nuclear envelope

  • Live-cell imaging with fluorescently tagged GHDC to monitor dynamics

  • Proximity labeling (BioID, APEX) to identify proteins in close proximity to GHDC

• Protein-protein interaction analysis:

  • Apply structural biology approaches to understand GHDC's GH3 domain function

  • Use protein microarrays to identify interaction partners

  • Consider hydrogen-deuterium exchange mass spectrometry for conformational studies

How might GHDC antibody research intersect with current trends in biomarker discovery?

The potential role of GHDC in mammary biology suggests several research applications:

• Biomarker development considerations:

  • Evaluate GHDC expression across breast cancer molecular subtypes

  • Assess correlation with treatment response and clinical outcomes

  • Investigate potential as a diagnostic or prognostic marker

• Methodological approaches:

  • Apply machine learning to identify patterns in GHDC expression

  • Use longitudinal sampling to assess GHDC as a dynamic biomarker

  • Consider liquid biopsy approaches for detecting GHDC in circulation

• Validation requirements:

  • Establish standardized assays for reproducible GHDC detection

  • Validate findings across multiple cohorts

  • Compare performance against established biomarkers

By addressing these questions with rigorous methodology, researchers can advance our understanding of GHDC biology and potential applications in biomedical research.